47 related articles for article (PubMed ID: 10656433)
1. Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.
Awada A; Albanell J; Canney PA; Dirix LY; Gil T; Cardoso F; Gascon P; Piccart MJ; Baselga J
Br J Cancer; 2008 May; 98(9):1500-7. PubMed ID: 18454159
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies.
von Mehren M; Bookman M; Meropol NJ; Weiner LM; Sherman E; Li J; Knoblauch R; Parekh T; Cohen RB
Cancer Chemother Pharmacol; 2015 May; 75(5):1047-55. PubMed ID: 25791363
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors.
Awada AH; Dumez H; Hendlisz A; Wolter P; Besse-Hammer T; Uttenreuther-Fischer M; Stopfer P; Fleischer F; Piccart M; Schöffski P
Invest New Drugs; 2013 Jun; 31(3):734-41. PubMed ID: 23161334
[TBL] [Abstract][Full Text] [Related]
4. A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.
Iyer G; Morris MJ; Rathkopf D; Slovin SF; Steers M; Larson SM; Schwartz LH; Curley T; DeLaCruz A; Ye Q; Heller G; Egorin MJ; Ivy SP; Rosen N; Scher HI; Solit DB
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1089-97. PubMed ID: 22124669
[TBL] [Abstract][Full Text] [Related]
5. A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer.
Moulder S; Gladish G; Ensor J; Gonzalez-Angulo AM; Cristofanilli M; Murray JL; Booser D; Giordano SH; Brewster A; Moore J; Rivera E; Hortobagyi GN; Tran HT
Cancer; 2012 May; 118(9):2378-84. PubMed ID: 22006179
[TBL] [Abstract][Full Text] [Related]
6. A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.
Chow LQ; Gustafson DL; O'Bryant CL; Gore L; Basche M; Holden SN; Morrow MC; Grolnic S; Creese BR; Roberts KL; Davis K; Addison R; Eckhardt SG
Cancer Chemother Pharmacol; 2008 Dec; 63(1):65-74. PubMed ID: 18320191
[TBL] [Abstract][Full Text] [Related]
7. A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours.
Eskens FA; Tresca P; Tosi D; Van Doorn L; Fontaine H; Van der Gaast A; Veyrat-Follet C; Oprea C; Hospitel M; Dieras V
Br J Cancer; 2014 Apr; 110(9):2170-7. PubMed ID: 24714750
[TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacokinetic study of paclitaxel by 24-hour intravenous infusion.
Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ohe Y; Nishio M; Kunikane H; Arioka H; Karato A; Omatsu H
Jpn J Cancer Res; 1994 Oct; 85(10):1057-62. PubMed ID: 7961108
[TBL] [Abstract][Full Text] [Related]
9. Preliminary trial of adjuvant surgery for advanced gastric cancer.
Suzuki T; Tanabe K; Taomoto J; Yamamoto H; Tokumoto N; Yoshida K; Ohdan H
Oncol Lett; 2010 Jul; 1(4):743-747. PubMed ID: 22966373
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis.
Tanabe K; Suzuki T; Tokumoto N; Yamamoto H; Yoshida K; Ohdan H
World J Surg Oncol; 2010 May; 8():40. PubMed ID: 20482840
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of docetaxel : recent developments.
Baker SD; Sparreboom A; Verweij J
Clin Pharmacokinet; 2006; 45(3):235-52. PubMed ID: 16509758
[TBL] [Abstract][Full Text] [Related]
12. Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer.
Park SH; Bang SM; Cho EK; Shin DB; Lee JH; Lee WK; Chung M
BMC Cancer; 2005 Jul; 5():87. PubMed ID: 16042786
[TBL] [Abstract][Full Text] [Related]
13. Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapy.
Vigano L; Locatelli A; Grasselli G; Gianni L
Invest New Drugs; 2001 May; 19(2):179-96. PubMed ID: 11392452
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel: a review of its use in non-small cell lung cancer.
Comer AM; Goa KL
Drugs Aging; 2000 Jul; 17(1):53-80. PubMed ID: 10933515
[TBL] [Abstract][Full Text] [Related]
15. A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors.
Van Den Neste E; de Valeriola D; Kerger J; Bleiberg H; Kusenda Z; Brassinne C; Bartholomeus S; Selleslags J; Hennebert P; Wythouck H; Cazenave I; Lefresne-Soulas F; Piccart M
Clin Cancer Res; 2000 Jan; 6(1):64-71. PubMed ID: 10656433
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel in combination with fluorouracil for advanced solid tumors.
Burris HA
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of docetaxel and topotecan in patients with solid tumors.
Tkaczuk KH; Zamboni WC; Tait NS; Meisenberg BR; Doyle LA; Edelman MJ; Hausner PF; Egorin MJ; Van Echo DA
Cancer Chemother Pharmacol; 2000; 46(6):442-8. PubMed ID: 11138457
[TBL] [Abstract][Full Text] [Related]
18. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
19. A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.
Pronk LC; Vasey P; Sparreboom A; Reigner B; Planting AS; Gordon RJ; Osterwalder B; Verweij J; Twelves C
Br J Cancer; 2000 Jul; 83(1):22-9. PubMed ID: 10883663
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
